Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Invokana in Type 2 Diabetes Mellitus on Metformin and Sitagliptin
NCT02025907Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Janssen Pharmaceutical. Started Feb 2014; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02025907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025907.